Arcus (RCUS) has recently seen 10,000 December $10 calls buy to open valued currently near $1.9M with shares down 47% YTD and the $835M Biotech trading 3.2X Sales and 0.85X Cash. RCUS is back to levels last seen in 2019 near an all-time low and short...